Bayer

Paris, France and Tarrytown, NY, 19-11-2012 — /europawire.eu/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion … Read the full press release →

18,000 patient Phase 3 outcomes study will evaluate the impact of antibody to PCSK9 on cardiovascular events Paris, France and Tarrytown, N.Y., 13-11-2012 — /europawire.eu/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the ODYSSEY … Read the full press release →

CVMP opinions on veterinary medicinal products 12-11-2012 — /europawire.eu/ — The Committee adopted by consensusa positive opinion for an initial marketing authorisation for Kexxtone continuous-release intraruminal device for cattle (monensin) from Eli Lilly and Company Limited. The product is intended for the reduction of … Read the full press release →

Significant effects of LEMTRADA™ vs. Rebif® described in CARE-MS I and CARE-MS II publications Paris, France, 12-11-2012 — /europawire.eu/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today the publication of results from the LEMTRADA™ (alemtuzumab) CARE-MS I and CARE-MS … Read the full press release →